Brief: Trinity Biotech Announces Collaboration With University At Buffalo To Commercialize Novel Biomarkers For Sjögren’S Syndrome
18/03/2026 12:34
March 18 (Reuters) - Trinity Biotech PLC TRIB.O: TRINITY BIOTECH ANNOUNCES COLLABORATION WITH UNIVERSITY AT BUFFALO TO COMMERCIALIZE NOVEL BIOMARKERS FOR SJÖGREN’S SYNDROME Source text: ID:nGNX75VcLF Further company coverage: TRIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM